Tranexamic acid for prevention of surgical bleeding: Review
The benefits are (mostly) clear. What are the risks?
Tranexamic acid (TXA) is a synthetic molecule derived from the amino acid lysine. TXA is a pro-coagulant that produces antifibrinolytic effects by reversibly blocking the sites where lysine binds to plasminogen, slowing down plasminogen’s clot-dissolving activity.
Epsilon-aminocaproic acid (EACA) is a related compound with antifibrinolytic activity but …
Keep reading with a 7-day free trial
Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.